Volume 27, Number 7—July 2021
Research
Multiplex Real-Time Reverse Transcription PCR for Influenza A Virus, Influenza B Virus, and Severe Acute Respiratory Syndrome Coronavirus 2
Table 5
Evaluation of the Influenza SARS-CoV-2 Multiplex Assay specificity*
Virus strain | Lineage | GISAID accession no. | Con† | Cycle threshold value |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Influenza A |
Influenza B |
SARS-CoV-2 |
|||||||||||||
Influenza A | |||||||||||||||
A/Florida/81/2018 | A(H1N1) pdm09 | EPI1310819 | 108.1 | 13.97 | 14.00 | 14.02 | 0 | 0 | 0 | 0 | 0 | 0 | |||
103.1 | 27.48 | 28.16 | 27.74 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/Kansas/14/2017 | A(H3N2) | EPI1653963 | 108.5 | 13.62 | 13.66 | 13.68 | 0 | 0 | 0 | 0 | 0 | 0 | |||
105.5 | 25.07 | 25.00 | 25.01 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/Ohio/35/2017 | A(H1N2)v | EPI1056728 | 106.9 | 14.71 | 14.90 | 14.84 | 0 | 0 | 0 | 0 | 0 | 0 | |||
101.9 | 30.91 | 31.25 | 30.99 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/chicken/Pennsyl- vania/298101- 4/2004 | A(H2N2) | EPI229365 | 109.5 | 15.60 | 15.66 | 15.74 | 0 | 0 | 0 | 0 | 0 | 0 | |||
103.5 | 33.40 | 33.20 | 34.71 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/Ohio/13/2017 | A(H3N2)v | EPI1056648 | 106.6 | 20.85 | 20.96 | 20.86 | 0 | 0 | 0 | 0 | 0 | 0 | |||
101.6 | 35.48 | 35.49 | 33.98 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/canine/Florida/ 43/2004 | A(H3N2) | 108.1 | 19.61 | 19.69 | 19.44 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
EPI98471 | 104.1 | 34.10 | 35.45 | 36.87 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
A/equine/Ohio/01/ 2003 | A(H3N8) | DQ124188§ | 108.4 | 16.50 | 16.70 | 16.68 | 0 | 0 | 0 | 0 | 0 | 0 | |||
103.4 | 31.01 | 31.55 | 31.07 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/Northern pintail/Washington /40964/2014 | A(H5N2) | EPI860995 | 109.4 | 16.39 | 16.43 | 16.49 | 0 | 0 | 0 | 0 | 0 | 0 | |||
104.4 | 36.89 | 36.45 | 34.43 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/gyrfalcon/Wash- ington/41088- 6/2014 | A(H5N8) | EPI569393 | 109.75 | 14.12 | 14.10 | 14.13 | 0 | 0 | 0 | 0 | 0 | 0 | |||
104.75 | 29.60 | 29.38 | 29.90 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/chicken/Califor- nia/32213–1/2000 |
A(H6N2) | EPI1915583 | 109.2 | 14.97 | 15.05 | 15.08 | 0 | 0 | 0 | 0 | 0 | 0 | |||
103.2 | 34.19 | 32.52 | 32.49 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/feline/New York/16-040082- 1/2016 | A(H7N2) | EPI985440 | 1010.2 | 15.76 | 15.94 | 16.00 | 0 | 0 | 0 | 0 | 0 | 0 | |||
105.2 | 28.16 | 28.30 | 28.46 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/Taiwan/1/2017 | A(H7N9) | EPI917065 | 109.5 | 16.69 | 16.90 | 16.99 | 0 | 0 | 0 | 0 | 0 | 0 | |||
103.5 | 32.20 | 33.11 | 32.53 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
A/Bangladesh/
0994/2011 |
A(H9N2) |
EPI445991 | 1010.5 | 18.03 | 18.14 | 18.21 | 0 | 0 | 0 | 0 | 0 | 0 | |||
104.5 |
34.25 |
35.32 |
36.90 |
0 |
0 |
0 |
0 |
0 |
0 |
||||||
Influenza B | |||||||||||||||
B/Maryland/15/ 2016 | B(Victoria) | EPI1255266 | 108.5 | 0 | 0 | 0 | 13.46 | 13.49 | 13.47 | 0 | 0 | 0 | |||
102.5 | 0 | 0 | 0 | 30.82 | 31.07 | 31.20 | 0 | 0 | 0 | ||||||
B/Phuket/3073/
2013 |
B (Yamagata) |
EPI1799818 | 108.9 | 0 | 0 | 0 | 13.66 | 13.67 | 13.68 | 0 | 0 | 0 | |||
102.9 |
0 |
0 |
0 |
31.87 |
31.77 |
32.18 |
0 |
0 |
0 |
||||||
SARS-CoV-2 | |||||||||||||||
2019-nCoV/USA- WA1/2020 | Beta-coronavirus | MT 576563 | 104.5 | 0 | 0 | 0 | 0 | 0 | 0 | 18.34 | 18.55 | 18.41 | |||
100.5 | 0 | 0 | 0 | 0 | 0 | 0 | 33.11 | 34.15 | 34.88 |
*Multiplex real-time reverse transcription PCR for influenza A virus, influenza B virus, and SARS-CoV-2. Evaluation conducted in triplicate. Con, concentration; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. ‡Concentration in relation to 50% tissue culture infectious dose. §GenBank accession number.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: May 13, 2021
Page updated: June 16, 2021
Page reviewed: June 16, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.